Previous 10 | Next 10 |
home / stock / sgen / sgen articles
According to the Global Data report, the pharma sector in Q3 2023 witnessed deals worth $28 billion, down 28% from the $54 billion recorded in Q2 2...
Truist Securities analyst Robyn Karnauskas reiterated a Buy rating on Pfizer, Inc. (NYSE: PFE), lowering the price target to $3...
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Shake Shack Inc (NYSE: SHAK) as his f...
Pfizer Inc (NYSE: PFE) agreed to donate the rights of royalties from sales of cancer drug Bavencio (avelumab) to the American Associ...
SystImmune and Bristol Myers Squibb & Co (NYSE: BMY) announced an exclusive license and collaboration agreement for Sy...
Seagen (NASDAQ:SGEN) has outperformed the market over the past 20 years by 11.34% on an annualized basis producing an average annual return of 18.8...
Seagen (NASDAQ:SGEN) has outperformed the market over the past 5 years by 17.92% on an annualized basis producing an average annual return of 29.45...
On CNBC’s "Mad Money Lightning Round," Jim Cramer said DocuSign, Inc. (NASDAQ: DOCU) is "going to have to come up with somet...
Seagen (NASDAQ:SGEN) has outperformed the market over the past 15 years by 11.59% on an annualized basis producing an average annual return of 22.4...
News, Short Squeeze, Breakout and More Instantly...